Infrequent mutations and no methylation of CDKN2A (p16/MTS1) and CDKN2B (p15/MTS2) in hepatocellular carcinoma in Taiwan

By Lin Y.-W.   Chen C.-H.   Huang G.-T.   Lee P.-H.   Wang J.-T.   Chen D.-S.   Lu F.-J.   Sheu J.-C.  

European Journal of Cancer, Vol. 34, Iss. 11, 1998-10 ,pp. : 1789-1795

Elsevier

Access to resources Recommend Favorite

CDKN2A exon-wise deletion status and novel somatic mutations in Indian glioma patients

By Sibin M.   Bhat Dhananjaya   Lavanya Ch   Jeru Manoj M.   Aakershita S.   Chetan G.  

Tumor Biology, Vol. 35, Iss. 2, 2014-02 ,pp. : 1467-1472

Springer Publishing Company

Access to resources Recommend Favorite

The Occurrence and the Type of Germline Mutations in the RET Gene in Patients with Medullary Thyroid Carcinoma and Their Unaffected Kindred's from Central Poland

By Paszko Z.   Sromek M.   Czetwertynska M.   Skasko E.   Czapczak D.   Wisniewska A.   Prokurat A.   Chrupek M.   Jagielska A.   Kozlowicz-Gudzinska I.  

Cancer Investigation, Vol. 25, Iss. 8, 2007-11 ,pp. : 742-749

Informa Healthcare

Access to resources Recommend Favorite

Prevalence of KRAS, BRAF, PI3K and EGFR mutations among Asian patients with metastatic colorectal cancer

By                  

Oncology Letters, Vol. 10, Iss. 4, 2015-01 ,pp. : 2519-2526

Spandidos Publications

Access to resources Recommend Favorite

Risk factors for medullary thyroid carcinoma: a pooled analysis

By Negri E.  

Cancer Causes and Control, Vol. 13, Iss. 4, 2002-05 ,pp. : 365-372

Springer Publishing Company

Access to resources Recommend Favorite